Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Manganese Priming with Sintilimab and Chemotherapy in Relapsed/Refractory Ovarian Cancer
NCT03989336Phase 2Completed
- Sponsor
- Chinese PLA General Hospital
- Start
- Dec 2020
- Primary completion
- May 2022
- Modality
- DNA Intercalators/Alkylators
- Countries
- 1
01
Overview
A Phase 2 trial of manganese chloride in ovarian cancer, sponsored by Chinese PLA General Hospital. Started Dec 2020; status: completed.
02
Drugs
manganese chloride
03
Conditions
ovarian cancer
Beyond the preview
Go deeper on NCT03989336.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT03989336.